{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:00Z","timestamp":1753890660101,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1003803"],"award-info":[{"award-number":["2018YFC1003803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019PH009"],"award-info":[{"award-number":["ZR2019PH009"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82125014"],"award-info":[{"award-number":["82125014"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071609, 81771541, 82171651, 81971352"],"award-info":[{"award-number":["82071609, 81771541, 82171651, 81971352"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Poor ovarian response (POR) remains one of the most challenging conditions in assisted reproduction technology. Previous studies seemed to indicate that growth hormone (GH) was a potential solution for the dilemma of POR; however, the role GH played on the low-prognosis patients diagnosed and stratified by the POSEIDON criteria remains indistinct.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study was performed among women with POR according to the POSEIDON criteria who failed a previous <jats:italic>in vitro<\/jats:italic> fertilization (IVF)\/intracytoplasmic sperm injection (ICSI) cycle, and the subsequent cycle was under GH cotreatment and conducted within 12 months. These participants were stratified into four groups according to the POSEIDON criteria. The comparison was implemented between the failed cycle and the cycle treated with GH. Generalized estimating equation (GEE) multivariate regression was applied for data analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 428 low-prognosis women were included in this study. GH supplementation improved the live birth rates (47.66%, 28.33%, 45.45%, and 24.07%; in groups 1, 2, 3, and 4, respectively) and the clinical pregnancy rates (OR 19.16, 95% CI 7.87\u201346.63, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; OR 7.44, 95% CI 1.65\u201333.55, <jats:italic>p<\/jats:italic> = 0.009; OR 10.19, 95% CI 2.39\u201343.52, <jats:italic>p<\/jats:italic> = 0.002; OR 27.63, 95% CI 4.46\u2013171.11, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; in groups 1, 2, 3, and 4, respectively) in all four POSEIDON groups. The number of oocytes retrieved was significantly elevated in the subgroups with normal ovarian reserve (IRR 1.47, 95% CI 1.36\u20131.59, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; IRR 1.31, 95% CI 1.15\u20131.49, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; in groups 1 and 2, respectively). The number of day-3 good-quality embryos was significantly elevated in the subgroups with either normal ovarian reserve or aged young (IRR 2.13, 95% CI 1.78\u20132.56, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; IRR 1.54, 95% CI 1.26\u20131.89, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; IRR 1.47, 95% CI 1.10\u20131.98, <jats:italic>p<\/jats:italic> = 0.010; in groups 1, 2, and 3, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Growth hormone cotreatment could ameliorate the pregnancy outcome for women with POR under the POSEIDON criteria who failed a previous IVF\/ICSI cycle. The application of growth hormone for low-prognosis women who experienced a failed cycle might be considered and further studied.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.790160","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T09:17:47Z","timestamp":1638523067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria"],"prefix":"10.3389","volume":"12","author":[{"given":"Xueying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A Systematic Review of Randomized Trials for the Treatment of Poor Ovarian Responders: Is There Any Light at the End of the Tunnel","volume":"96","author":"Polyzos","year":"2011","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE Consensus on the Definition of 'Poor Response' to Ovarian Stimulation for In Vitro Fertilization: The Bologna Criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod (Oxford England)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.18.03511-5","article-title":"Novel Approaches for Diagnosis and Management of Low Prognosis Patients in Assisted Reproductive Technology: The POSEIDON Concept","volume":"61","author":"Conforti","year":"2019","journal-title":"Panminerva Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu139","article-title":"The Bologna Criteria for the Definition of Poor Ovarian Responders: Is There a Need for Revision","volume":"29","author":"Ferraretti","year":"2014","journal-title":"Hum Reprod (Oxford England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A New More Detailed Stratification of Low Responders to Ovarian Stimulation: From a Poor Ovarian Response to a Low Prognosis Concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.theriogenology.2008.12.015","article-title":"Involvement of Growth Hormone (GH) and Insulin-Like Growth Factor (IGF) System in Ovarian Folliculogenesis","volume":"71","author":"Silva","year":"2009","journal-title":"Theriogenology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/REP-14-0494","article-title":"A Direct Action for GH in Improvement of Oocyte Quality in Poor-Responder Patients","volume":"149","author":"Weall","year":"2015","journal-title":"Reprod (Cambridge England)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/bbrc.1999.2072","article-title":"Morphological Assessment of the Effect of Growth Hormone on Preantral Follicles From 11-Day-Old Mice in an In Vitro Culture System","volume":"268","author":"Kobayashi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/endo-118-4-1401","article-title":"Growth Hormone Enhances Follicle-Stimulating Hormone-Induced Differentiation of Cultured Rat Granulosa Cells","volume":"118","author":"Jia","year":"1986","journal-title":"Endocrinology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.10.020","article-title":"The Effects of Growth Hormone on Clinical Outcomes After Frozen-Thawed Embryo Transfer","volume":"133","author":"Xue-Mei","year":"2016","journal-title":"Int J Gynaecol Obstetrics: Off Organ Int Fed Gynaecol Obstetrics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-020-00648-2","article-title":"Growth Hormone Alleviates Oxidative Stress and Improves the IVF Outcomes of Poor Ovarian Responders: A Randomized Controlled Trial","volume":"18","author":"Gong","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.08.018","article-title":"Growth Hormone During In Vitro Fertilization in Older Women Modulates the Density of Receptors in Granulosa Cells, With Improved Pregnancy Outcomes","volume":"110","author":"Regan","year":"2018","journal-title":"Fertil Steril"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/REP-18-0529","article-title":"Evidence That Growth Hormone can Improve Mitochondrial Function in Oocytes From Aged Mice","volume":"157","author":"Hou","year":"2018","journal-title":"Reprod (Cambridge England)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.fertnstert.2020.03.007","article-title":"Growth Hormone Cotreatment for Poor Responders Undergoing In Vitro Fertilization Cycles: A Systematic Review and Meta-Analysis","volume":"114","author":"Cozzolino","year":"2020","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz046","article-title":"Adjuvant Treatment Strategies in Ovarian Stimulation for Poor Responders Undergoing IVF: A Systematic Review and Network Meta-Analysis","volume":"26","author":"Zhang","year":"2020","journal-title":"Hum Reprod Update"},{"key":"B17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and Performance Characteristics of Anti-M\u00fcllerian Hormone and Antral Follicle Count as Biomarkers of Ovarian Response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing Ovarian Response: Antral Follicle Count Versus Anti-M\u00fcllerian Hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a136618","article-title":"Embryo Scoring as a Prognostic Tool in IVF Treatment","volume":"2","author":"Puissant","year":"1987","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(00)00518-5","article-title":"Blastocyst Score Affects Implantation and Pregnancy Outcome: Towards a Single Blastocyst Transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12958-020-00632-w","article-title":"The Effect of Growth Hormone Supplementation in Poor Ovarian Responders Undergoing IVF or ICSI: A Meta-Analysis of Randomized Controlled Trials","volume":"18","author":"Yang","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The Addition of Growth Hormone Adjuvant Therapy to the Long Down Regulation Protocol in Poor Responders Undergoing In Vitro Fertilization: Randomized Control Trial","volume":"228","author":"Dakhly","year":"2018","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the Addition of Growth Hormone to the In Vitro Fertilization\/Intracytoplasmic Sperm Injection Antagonist Protocol Improve Outcomes in Poor Responders? A Randomized, Controlled Trial","volume":"105","author":"Bassiouny","year":"2016","journal-title":"Fertil Steril"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.05.034","article-title":"Addition of Growth Hormone to the Microflare Stimulation Protocol Among Women With Poor Ovarian Response","volume":"131","author":"Bayoumi","year":"2015","journal-title":"Int J Gynaecol Obstetrics: Off Organ Int Fed Gynaecol Obstetrics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00775","article-title":"The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing In Vitro Fertilization\/Intracytoplasmic Sperm Injection Treatment: A Retrospective Study Based on POSEIDON Criteria","volume":"10","author":"Cai","year":"2019","journal-title":"Front Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00485","article-title":"Growth Hormone Promotes In Vitro Maturation of Human Oocytes","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.790160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T09:17:52Z","timestamp":1638523072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.790160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":26,"alternative-id":["10.3389\/fendo.2021.790160"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.790160","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"article-number":"790160"}}